Search All News
The new trial has shown promising results in evaluating a first-line combination therapy for pancreatic ductal adenocarcinoma (PDAC).
Dr. Manji is a leading expert in pancreatic cancer and a physician-scientist devoted to conducting translational research with the overall goal of developing new treatments for cancer.
Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
Today.com quotes expert Fay Kastrinos, MD, on a new study that shows rates of pancreatic cancer are on the rise in young women. “We don’t want alarms going off but the trend is important," she notes.
- February 13, 2023
HICCC Director Anil Rustgi, MD, is being honored for his major contributions in advancing the care of patients with digestive diseases through clinical or translational research.
- November 30, 2022
Peter encourages others to look into clinical trials and not lose hope.
- November 14, 2022
Ten years ago, Jan Hilgeman was diagnosed with inoperable pancreatic cancer. Today, she is grateful to her care team and the friends and family who have stood by her side every step of the way.
- June 24, 2022
A new study by Iok In Christine Chio, PhD, provides key insights towards a possible treatment that can toggle this molecular switch to block the spread of pancreatic cancer to other organs.
- March 8, 2022
As one of the early pioneers of surgical pathology, Dr. Frantz made a series of important cancer discoveries, including key studies of the surgical pathology of insulin-secreting pancreatic tumors.
Source:CUIMC NewsroomMarch 12, 2021
Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer according to a new study, co-led by HICCC Director Anil K. Rustgi, MD.
- November 13, 2020
November marks Pancreatic Cancer Awareness month, and in this in-depth Q+A, Dr. Gulam Manji takes us through the exciting advances in pancreatic cancer treatment and research.
- November 11, 2020
Columbia University biologist Kenneth Olive, PhD, isn’t afraid to tackle a hard problem. He has dedicated his life to finding a cure for pancreatic cancer, one of the toughest types of cancer to treat
- September 10, 2020
The Ken Olive lab has been awarded a new gift to support his innovative research in pancreatic cancer.